Global Immuno-oncology Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Immuno-oncology Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Immuno-oncology Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Immuno-oncology Drugs by Country/Region, 2017, 2022 & 2028

2.2 Immuno-oncology Drugs Segment by Type

2.2.1 Immune Checkpoint Inhibitors

2.2.2 Immune System Modulators

2.2.3 Cancer Vaccines

2.2.4 Oncolytic Virus

2.2.5 Others

2.3 Immuno-oncology Drugs Sales by Type

2.3.1 Global Immuno-oncology Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Immuno-oncology Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Immuno-oncology Drugs Sale Price by Type (2017-2022)

2.4 Immuno-oncology Drugs Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.4.3 Ambulatory Surgical Centers

2.5 Immuno-oncology Drugs Sales by Application

2.5.1 Global Immuno-oncology Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Immuno-oncology Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Immuno-oncology Drugs Sale Price by Application (2017-2022)

3 Global Immuno-oncology Drugs by Company

3.1 Global Immuno-oncology Drugs Breakdown Data by Company

3.1.1 Global Immuno-oncology Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Immuno-oncology Drugs Sales Market Share by Company (2020-2022)

3.2 Global Immuno-oncology Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Immuno-oncology Drugs Revenue by Company (2020-2022)

3.2.2 Global Immuno-oncology Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Immuno-oncology Drugs Sale Price by Company

3.4 Key Manufacturers Immuno-oncology Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Immuno-oncology Drugs Product Location Distribution

3.4.2 Players Immuno-oncology Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Immuno-oncology Drugs by Geographic Region

4.1 World Historic Immuno-oncology Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Immuno-oncology Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Immuno-oncology Drugs Annual Revenue by Geographic Region

4.2 World Historic Immuno-oncology Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Immuno-oncology Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Immuno-oncology Drugs Annual Revenue by Country/Region

4.3 Americas Immuno-oncology Drugs Sales Growth

4.4 APAC Immuno-oncology Drugs Sales Growth

4.5 Europe Immuno-oncology Drugs Sales Growth

4.6 Middle East & Africa Immuno-oncology Drugs Sales Growth

5 Americas

5.1 Americas Immuno-oncology Drugs Sales by Country

5.1.1 Americas Immuno-oncology Drugs Sales by Country (2017-2022)

5.1.2 Americas Immuno-oncology Drugs Revenue by Country (2017-2022)

5.2 Americas Immuno-oncology Drugs Sales by Type

5.3 Americas Immuno-oncology Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Immuno-oncology Drugs Sales by Region

6.1.1 APAC Immuno-oncology Drugs Sales by Region (2017-2022)

6.1.2 APAC Immuno-oncology Drugs Revenue by Region (2017-2022)

6.2 APAC Immuno-oncology Drugs Sales by Type

6.3 APAC Immuno-oncology Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Immuno-oncology Drugs by Country

7.1.1 Europe Immuno-oncology Drugs Sales by Country (2017-2022)

7.1.2 Europe Immuno-oncology Drugs Revenue by Country (2017-2022)

7.2 Europe Immuno-oncology Drugs Sales by Type

7.3 Europe Immuno-oncology Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Immuno-oncology Drugs by Country

8.1.1 Middle East & Africa Immuno-oncology Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Immuno-oncology Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Immuno-oncology Drugs Sales by Type

8.3 Middle East & Africa Immuno-oncology Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Immuno-oncology Drugs

10.3 Manufacturing Process Analysis of Immuno-oncology Drugs

10.4 Industry Chain Structure of Immuno-oncology Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Immuno-oncology Drugs Distributors

11.3 Immuno-oncology Drugs Customer

12 World Forecast Review for Immuno-oncology Drugs by Geographic Region

12.1 Global Immuno-oncology Drugs Market Size Forecast by Region

12.1.1 Global Immuno-oncology Drugs Forecast by Region (2023-2028)

12.1.2 Global Immuno-oncology Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Immuno-oncology Drugs Forecast by Type

12.7 Global Immuno-oncology Drugs Forecast by Application

13 Key Players Analysis

13.1 Amgen, Inc

13.1.1 Amgen, Inc Company Information

13.1.2 Amgen, Inc Immuno-oncology Drugs Product Offered

13.1.3 Amgen, Inc Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Amgen, Inc Main Business Overview

13.1.5 Amgen, Inc Latest Developments

13.2 AstraZeneca, Plc

13.2.1 AstraZeneca, Plc Company Information

13.2.2 AstraZeneca, Plc Immuno-oncology Drugs Product Offered

13.2.3 AstraZeneca, Plc Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 AstraZeneca, Plc Main Business Overview

13.2.5 AstraZeneca, Plc Latest Developments

13.3 Bristol-Myers Squibb

13.3.1 Bristol-Myers Squibb Company Information

13.3.2 Bristol-Myers Squibb Immuno-oncology Drugs Product Offered

13.3.3 Bristol-Myers Squibb Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Bristol-Myers Squibb Main Business Overview

13.3.5 Bristol-Myers Squibb Latest Developments

13.4 Celgene Corporation

13.4.1 Celgene Corporation Company Information

13.4.2 Celgene Corporation Immuno-oncology Drugs Product Offered

13.4.3 Celgene Corporation Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Celgene Corporation Main Business Overview

13.4.5 Celgene Corporation Latest Developments

13.5 Eli Lilly and Company

13.5.1 Eli Lilly and Company Company Information

13.5.2 Eli Lilly and Company Immuno-oncology Drugs Product Offered

13.5.3 Eli Lilly and Company Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Eli Lilly and Company Main Business Overview

13.5.5 Eli Lilly and Company Latest Developments

13.6 Merck & Co.

13.6.1 Merck & Co. Company Information

13.6.2 Merck & Co. Immuno-oncology Drugs Product Offered

13.6.3 Merck & Co. Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Merck & Co. Main Business Overview

13.6.5 Merck & Co. Latest Developments

13.7 Hoffmann-La Roche AG

13.7.1 Hoffmann-La Roche AG Company Information

13.7.2 Hoffmann-La Roche AG Immuno-oncology Drugs Product Offered

13.7.3 Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Hoffmann-La Roche AG Main Business Overview

13.7.5 Hoffmann-La Roche AG Latest Developments

13.8 Johnson & Johnson

13.8.1 Johnson & Johnson Company Information

13.8.2 Johnson & Johnson Immuno-oncology Drugs Product Offered

13.8.3 Johnson & Johnson Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Johnson & Johnson Main Business Overview

13.8.5 Johnson & Johnson Latest Developments

13.9 Novartis International AG

13.9.1 Novartis International AG Company Information

13.9.2 Novartis International AG Immuno-oncology Drugs Product Offered

13.9.3 Novartis International AG Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Novartis International AG Main Business Overview

13.9.5 Novartis International AG Latest Developments

13.10 AbbVie, Inc.

13.10.1 AbbVie, Inc. Company Information

13.10.2 AbbVie, Inc. Immuno-oncology Drugs Product Offered

13.10.3 AbbVie, Inc. Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 AbbVie, Inc. Main Business Overview

13.10.5 AbbVie, Inc. Latest Developments

13.11 Pfizer Inc.

13.11.1 Pfizer Inc. Company Information

13.11.2 Pfizer Inc. Immuno-oncology Drugs Product Offered

13.11.3 Pfizer Inc. Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Pfizer Inc. Main Business Overview

13.11.5 Pfizer Inc. Latest Developments

13.12 Sanofi S.A.

13.12.1 Sanofi S.A. Company Information

13.12.2 Sanofi S.A. Immuno-oncology Drugs Product Offered

13.12.3 Sanofi S.A. Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Sanofi S.A. Main Business Overview

13.12.5 Sanofi S.A. Latest Developments

13.13 EMD Serono, Inc.

13.13.1 EMD Serono, Inc. Company Information

13.13.2 EMD Serono, Inc. Immuno-oncology Drugs Product Offered

13.13.3 EMD Serono, Inc. Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 EMD Serono, Inc. Main Business Overview

13.13.5 EMD Serono, Inc. Latest Developments

13.14 Gilead Sciences Inc.

13.14.1 Gilead Sciences Inc. Company Information

13.14.2 Gilead Sciences Inc. Immuno-oncology Drugs Product Offered

13.14.3 Gilead Sciences Inc. Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Gilead Sciences Inc. Main Business Overview

13.14.5 Gilead Sciences Inc. Latest Developments

13.15 Prometheus Therapeutics & Diagnostics

13.15.1 Prometheus Therapeutics & Diagnostics Company Information

13.15.2 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Product Offered

13.15.3 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Prometheus Therapeutics & Diagnostics Main Business Overview

13.15.5 Prometheus Therapeutics & Diagnostics Latest Developments

13.16 Aduro BioTech

13.16.1 Aduro BioTech Company Information

13.16.2 Aduro BioTech Immuno-oncology Drugs Product Offered

13.16.3 Aduro BioTech Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Aduro BioTech Main Business Overview

13.16.5 Aduro BioTech Latest Developments

13.17 Galena Biopharma

13.17.1 Galena Biopharma Company Information

13.17.2 Galena Biopharma Immuno-oncology Drugs Product Offered

13.17.3 Galena Biopharma Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Galena Biopharma Main Business Overview

13.17.5 Galena Biopharma Latest Developments

13.18 Bavarian Nordic

13.18.1 Bavarian Nordic Company Information

13.18.2 Bavarian Nordic Immuno-oncology Drugs Product Offered

13.18.3 Bavarian Nordic Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Bavarian Nordic Main Business Overview

13.18.5 Bavarian Nordic Latest Developments

13.19 Celldex Therapeutics

13.19.1 Celldex Therapeutics Company Information

13.19.2 Celldex Therapeutics Immuno-oncology Drugs Product Offered

13.19.3 Celldex Therapeutics Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Celldex Therapeutics Main Business Overview

13.19.5 Celldex Therapeutics Latest Developments

13.20 ImmunoCellular Therapeutics

13.20.1 ImmunoCellular Therapeutics Company Information

13.20.2 ImmunoCellular Therapeutics Immuno-oncology Drugs Product Offered

13.20.3 ImmunoCellular Therapeutics Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 ImmunoCellular Therapeutics Main Business Overview

13.20.5 ImmunoCellular Therapeutics Latest Developments

13.21 Incyte

13.21.1 Incyte Company Information

13.21.2 Incyte Immuno-oncology Drugs Product Offered

13.21.3 Incyte Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Incyte Main Business Overview

13.21.5 Incyte Latest Developments

13.22 Dendreon Corporation

13.22.1 Dendreon Corporation Company Information

13.22.2 Dendreon Corporation Immuno-oncology Drugs Product Offered

13.22.3 Dendreon Corporation Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Dendreon Corporation Main Business Overview

13.22.5 Dendreon Corporation Latest Developments

13.23 Agilent Technologies Inc.

13.23.1 Agilent Technologies Inc. Company Information

13.23.2 Agilent Technologies Inc. Immuno-oncology Drugs Product Offered

13.23.3 Agilent Technologies Inc. Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Agilent Technologies Inc. Main Business Overview

13.23.5 Agilent Technologies Inc. Latest Developments

13.24 Agenus Inc.

13.24.1 Agenus Inc. Company Information

13.24.2 Agenus Inc. Immuno-oncology Drugs Product Offered

13.24.3 Agenus Inc. Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.24.4 Agenus Inc. Main Business Overview

13.24.5 Agenus Inc. Latest Developments

13.25 Enzo Biochem, Inc.

13.25.1 Enzo Biochem, Inc. Company Information

13.25.2 Enzo Biochem, Inc. Immuno-oncology Drugs Product Offered

13.25.3 Enzo Biochem, Inc. Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.25.4 Enzo Biochem, Inc. Main Business Overview

13.25.5 Enzo Biochem, Inc. Latest Developments

13.26 Lonza Group

13.26.1 Lonza Group Company Information

13.26.2 Lonza Group Immuno-oncology Drugs Product Offered

13.26.3 Lonza Group Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.26.4 Lonza Group Main Business Overview

13.26.5 Lonza Group Latest Developments

13.27 Bio-Rad Laboratories, Inc.

13.27.1 Bio-Rad Laboratories, Inc. Company Information

13.27.2 Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Product Offered

13.27.3 Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.27.4 Bio-Rad Laboratories, Inc. Main Business Overview

13.27.5 Bio-Rad Laboratories, Inc. Latest Developments

13.28 Avantor, Inc.

13.28.1 Avantor, Inc. Company Information

13.28.2 Avantor, Inc. Immuno-oncology Drugs Product Offered

13.28.3 Avantor, Inc. Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.28.4 Avantor, Inc. Main Business Overview

13.28.5 Avantor, Inc. Latest Developments

13.29 Spring Bank Pharmaceuticals, Inc.

13.29.1 Spring Bank Pharmaceuticals, Inc. Company Information

13.29.2 Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Product Offered

13.29.3 Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.29.4 Spring Bank Pharmaceuticals, Inc. Main Business Overview

13.29.5 Spring Bank Pharmaceuticals, Inc. Latest Developments

13.30 Ferring Pharmaceuticals

13.30.1 Ferring Pharmaceuticals Company Information

13.30.2 Ferring Pharmaceuticals Immuno-oncology Drugs Product Offered

13.30.3 Ferring Pharmaceuticals Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.30.4 Ferring Pharmaceuticals Main Business Overview

13.30.5 Ferring Pharmaceuticals Latest Developments

14 Research Findings and Conclusion

Table 1. Immuno-oncology Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Immuno-oncology Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Immune Checkpoint Inhibitors

Table 4. Major Players of Immune System Modulators

Table 5. Major Players of Cancer Vaccines

Table 6. Major Players of Oncolytic Virus

Table 7. Major Players of Others

Table 8. Global Immuno-oncology Drugs Sales by Type (2017-2022) & (K Units)

Table 9. Global Immuno-oncology Drugs Sales Market Share by Type (2017-2022)

Table 10. Global Immuno-oncology Drugs Revenue by Type (2017-2022) & ($ million)

Table 11. Global Immuno-oncology Drugs Revenue Market Share by Type (2017-2022)

Table 12. Global Immuno-oncology Drugs Sale Price by Type (2017-2022) & (USD/Unit)

Table 13. Global Immuno-oncology Drugs Sales by Application (2017-2022) & (K Units)

Table 14. Global Immuno-oncology Drugs Sales Market Share by Application (2017-2022)

Table 15. Global Immuno-oncology Drugs Revenue by Application (2017-2022)

Table 16. Global Immuno-oncology Drugs Revenue Market Share by Application (2017-2022)

Table 17. Global Immuno-oncology Drugs Sale Price by Application (2017-2022) & (USD/Unit)

Table 18. Global Immuno-oncology Drugs Sales by Company (2020-2022) & (K Units)

Table 19. Global Immuno-oncology Drugs Sales Market Share by Company (2020-2022)

Table 20. Global Immuno-oncology Drugs Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Immuno-oncology Drugs Revenue Market Share by Company (2020-2022)

Table 22. Global Immuno-oncology Drugs Sale Price by Company (2020-2022) & (USD/Unit)

Table 23. Key Manufacturers Immuno-oncology Drugs Producing Area Distribution and Sales Area

Table 24. Players Immuno-oncology Drugs Products Offered

Table 25. Immuno-oncology Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Immuno-oncology Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 29. Global Immuno-oncology Drugs Sales Market Share Geographic Region (2017-2022)

Table 30. Global Immuno-oncology Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Immuno-oncology Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Immuno-oncology Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 33. Global Immuno-oncology Drugs Sales Market Share by Country/Region (2017-2022)

Table 34. Global Immuno-oncology Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Immuno-oncology Drugs Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Immuno-oncology Drugs Sales by Country (2017-2022) & (K Units)

Table 37. Americas Immuno-oncology Drugs Sales Market Share by Country (2017-2022)

Table 38. Americas Immuno-oncology Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Immuno-oncology Drugs Revenue Market Share by Country (2017-2022)

Table 40. Americas Immuno-oncology Drugs Sales by Type (2017-2022) & (K Units)

Table 41. Americas Immuno-oncology Drugs Sales Market Share by Type (2017-2022)

Table 42. Americas Immuno-oncology Drugs Sales by Application (2017-2022) & (K Units)

Table 43. Americas Immuno-oncology Drugs Sales Market Share by Application (2017-2022)

Table 44. APAC Immuno-oncology Drugs Sales by Region (2017-2022) & (K Units)

Table 45. APAC Immuno-oncology Drugs Sales Market Share by Region (2017-2022)

Table 46. APAC Immuno-oncology Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Immuno-oncology Drugs Revenue Market Share by Region (2017-2022)

Table 48. APAC Immuno-oncology Drugs Sales by Type (2017-2022) & (K Units)

Table 49. APAC Immuno-oncology Drugs Sales Market Share by Type (2017-2022)

Table 50. APAC Immuno-oncology Drugs Sales by Application (2017-2022) & (K Units)

Table 51. APAC Immuno-oncology Drugs Sales Market Share by Application (2017-2022)

Table 52. Europe Immuno-oncology Drugs Sales by Country (2017-2022) & (K Units)

Table 53. Europe Immuno-oncology Drugs Sales Market Share by Country (2017-2022)

Table 54. Europe Immuno-oncology Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Immuno-oncology Drugs Revenue Market Share by Country (2017-2022)

Table 56. Europe Immuno-oncology Drugs Sales by Type (2017-2022) & (K Units)

Table 57. Europe Immuno-oncology Drugs Sales Market Share by Type (2017-2022)

Table 58. Europe Immuno-oncology Drugs Sales by Application (2017-2022) & (K Units)

Table 59. Europe Immuno-oncology Drugs Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Immuno-oncology Drugs Sales by Country (2017-2022) & (K Units)

Table 61. Middle East & Africa Immuno-oncology Drugs Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Immuno-oncology Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Immuno-oncology Drugs Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Immuno-oncology Drugs Sales by Type (2017-2022) & (K Units)

Table 65. Middle East & Africa Immuno-oncology Drugs Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Immuno-oncology Drugs Sales by Application (2017-2022) & (K Units)

Table 67. Middle East & Africa Immuno-oncology Drugs Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Immuno-oncology Drugs

Table 69. Key Market Challenges & Risks of Immuno-oncology Drugs

Table 70. Key Industry Trends of Immuno-oncology Drugs

Table 71. Immuno-oncology Drugs Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Immuno-oncology Drugs Distributors List

Table 74. Immuno-oncology Drugs Customer List

Table 75. Global Immuno-oncology Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 76. Global Immuno-oncology Drugs Sales Market Forecast by Region

Table 77. Global Immuno-oncology Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Immuno-oncology Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Immuno-oncology Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 80. Americas Immuno-oncology Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Immuno-oncology Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 82. APAC Immuno-oncology Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Immuno-oncology Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Europe Immuno-oncology Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Immuno-oncology Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Middle East & Africa Immuno-oncology Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Immuno-oncology Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 88. Global Immuno-oncology Drugs Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Immuno-oncology Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Immuno-oncology Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Immuno-oncology Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 92. Global Immuno-oncology Drugs Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Immuno-oncology Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Immuno-oncology Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 95. Amgen, Inc Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 96. Amgen, Inc Immuno-oncology Drugs Product Offered

Table 97. Amgen, Inc Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 98. Amgen, Inc Main Business

Table 99. Amgen, Inc Latest Developments

Table 100. AstraZeneca, Plc Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 101. AstraZeneca, Plc Immuno-oncology Drugs Product Offered

Table 102. AstraZeneca, Plc Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 103. AstraZeneca, Plc Main Business

Table 104. AstraZeneca, Plc Latest Developments

Table 105. Bristol-Myers Squibb Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 106. Bristol-Myers Squibb Immuno-oncology Drugs Product Offered

Table 107. Bristol-Myers Squibb Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 108. Bristol-Myers Squibb Main Business

Table 109. Bristol-Myers Squibb Latest Developments

Table 110. Celgene Corporation Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 111. Celgene Corporation Immuno-oncology Drugs Product Offered

Table 112. Celgene Corporation Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 113. Celgene Corporation Main Business

Table 114. Celgene Corporation Latest Developments

Table 115. Eli Lilly and Company Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 116. Eli Lilly and Company Immuno-oncology Drugs Product Offered

Table 117. Eli Lilly and Company Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 118. Eli Lilly and Company Main Business

Table 119. Eli Lilly and Company Latest Developments

Table 120. Merck & Co. Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 121. Merck & Co. Immuno-oncology Drugs Product Offered

Table 122. Merck & Co. Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 123. Merck & Co. Main Business

Table 124. Merck & Co. Latest Developments

Table 125. Hoffmann-La Roche AG Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 126. Hoffmann-La Roche AG Immuno-oncology Drugs Product Offered

Table 127. Hoffmann-La Roche AG Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 128. Hoffmann-La Roche AG Main Business

Table 129. Hoffmann-La Roche AG Latest Developments

Table 130. Johnson & Johnson Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 131. Johnson & Johnson Immuno-oncology Drugs Product Offered

Table 132. Johnson & Johnson Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 133. Johnson & Johnson Main Business

Table 134. Johnson & Johnson Latest Developments

Table 135. Novartis International AG Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 136. Novartis International AG Immuno-oncology Drugs Product Offered

Table 137. Novartis International AG Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 138. Novartis International AG Main Business

Table 139. Novartis International AG Latest Developments

Table 140. AbbVie, Inc. Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 141. AbbVie, Inc. Immuno-oncology Drugs Product Offered

Table 142. AbbVie, Inc. Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 143. AbbVie, Inc. Main Business

Table 144. AbbVie, Inc. Latest Developments

Table 145. Pfizer Inc. Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 146. Pfizer Inc. Immuno-oncology Drugs Product Offered

Table 147. Pfizer Inc. Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 148. Pfizer Inc. Main Business

Table 149. Pfizer Inc. Latest Developments

Table 150. Sanofi S.A. Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 151. Sanofi S.A. Immuno-oncology Drugs Product Offered

Table 152. Sanofi S.A. Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 153. Sanofi S.A. Main Business

Table 154. Sanofi S.A. Latest Developments

Table 155. EMD Serono, Inc. Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 156. EMD Serono, Inc. Immuno-oncology Drugs Product Offered

Table 157. EMD Serono, Inc. Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 158. EMD Serono, Inc. Main Business

Table 159. EMD Serono, Inc. Latest Developments

Table 160. Gilead Sciences Inc. Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 161. Gilead Sciences Inc. Immuno-oncology Drugs Product Offered

Table 162. Gilead Sciences Inc. Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 163. Gilead Sciences Inc. Main Business

Table 164. Gilead Sciences Inc. Latest Developments

Table 165. Prometheus Therapeutics & Diagnostics Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 166. Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Product Offered

Table 167. Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 168. Prometheus Therapeutics & Diagnostics Main Business

Table 169. Prometheus Therapeutics & Diagnostics Latest Developments

Table 170. Aduro BioTech Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 171. Aduro BioTech Immuno-oncology Drugs Product Offered

Table 172. Aduro BioTech Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 173. Aduro BioTech Main Business

Table 174. Aduro BioTech Latest Developments

Table 175. Galena Biopharma Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 176. Galena Biopharma Immuno-oncology Drugs Product Offered

Table 177. Galena Biopharma Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 178. Galena Biopharma Main Business

Table 179. Galena Biopharma Latest Developments

Table 180. Bavarian Nordic Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 181. Bavarian Nordic Immuno-oncology Drugs Product Offered

Table 182. Bavarian Nordic Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 183. Bavarian Nordic Main Business

Table 184. Bavarian Nordic Latest Developments

Table 185. Celldex Therapeutics Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 186. Celldex Therapeutics Immuno-oncology Drugs Product Offered

Table 187. Celldex Therapeutics Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 188. Celldex Therapeutics Main Business

Table 189. Celldex Therapeutics Latest Developments

Table 190. ImmunoCellular Therapeutics Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 191. ImmunoCellular Therapeutics Immuno-oncology Drugs Product Offered

Table 192. ImmunoCellular Therapeutics Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 193. ImmunoCellular Therapeutics Main Business

Table 194. ImmunoCellular Therapeutics Latest Developments

Table 195. Incyte Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 196. Incyte Immuno-oncology Drugs Product Offered

Table 197. Incyte Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 198. Incyte Main Business

Table 199. Incyte Latest Developments

Table 200. Dendreon Corporation Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 201. Dendreon Corporation Immuno-oncology Drugs Product Offered

Table 202. Dendreon Corporation Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 203. Dendreon Corporation Main Business

Table 204. Dendreon Corporation Latest Developments

Table 205. Agilent Technologies Inc. Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 206. Agilent Technologies Inc. Immuno-oncology Drugs Product Offered

Table 207. Agilent Technologies Inc. Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 208. Agilent Technologies Inc. Main Business

Table 209. Agilent Technologies Inc. Latest Developments

Table 210. Agenus Inc. Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 211. Agenus Inc. Immuno-oncology Drugs Product Offered

Table 212. Agenus Inc. Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 213. Agenus Inc. Main Business

Table 214. Agenus Inc. Latest Developments

Table 215. Enzo Biochem, Inc. Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 216. Enzo Biochem, Inc. Immuno-oncology Drugs Product Offered

Table 217. Enzo Biochem, Inc. Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 218. Enzo Biochem, Inc. Main Business

Table 219. Enzo Biochem, Inc. Latest Developments

Table 220. Lonza Group Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 221. Lonza Group Immuno-oncology Drugs Product Offered

Table 222. Lonza Group Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 223. Lonza Group Main Business

Table 224. Lonza Group Latest Developments

Table 225. Bio-Rad Laboratories, Inc. Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 226. Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Product Offered

Table 227. Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 228. Bio-Rad Laboratories, Inc. Main Business

Table 229. Bio-Rad Laboratories, Inc. Latest Developments

Table 230. Avantor, Inc. Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 231. Avantor, Inc. Immuno-oncology Drugs Product Offered

Table 232. Avantor, Inc. Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 233. Avantor, Inc. Main Business

Table 234. Avantor, Inc. Latest Developments

Table 235. Spring Bank Pharmaceuticals, Inc. Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 236. Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Product Offered

Table 237. Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 238. Spring Bank Pharmaceuticals, Inc. Main Business

Table 239. Spring Bank Pharmaceuticals, Inc. Latest Developments

Table 240. Ferring Pharmaceuticals Basic Information, Immuno-oncology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 241. Ferring Pharmaceuticals Immuno-oncology Drugs Product Offered

Table 242. Ferring Pharmaceuticals Immuno-oncology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 243. Ferring Pharmaceuticals Main Business

Table 244. Ferring Pharmaceuticals Latest Developments

List of Figures

Figure 1. Picture of Immuno-oncology Drugs

Figure 2. Immuno-oncology Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Immuno-oncology Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Immuno-oncology Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Immuno-oncology Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Immune Checkpoint Inhibitors

Figure 10. Product Picture of Immune System Modulators

Figure 11. Product Picture of Cancer Vaccines

Figure 12. Product Picture of Oncolytic Virus

Figure 13. Product Picture of Others

Figure 14. Global Immuno-oncology Drugs Sales Market Share by Type in 2021

Figure 15. Global Immuno-oncology Drugs Revenue Market Share by Type (2017-2022)

Figure 16. Immuno-oncology Drugs Consumed in Hospitals

Figure 17. Global Immuno-oncology Drugs Market: Hospitals (2017-2022) & (K Units)

Figure 18. Immuno-oncology Drugs Consumed in Clinics

Figure 19. Global Immuno-oncology Drugs Market: Clinics (2017-2022) & (K Units)

Figure 20. Immuno-oncology Drugs Consumed in Ambulatory Surgical Centers

Figure 21. Global Immuno-oncology Drugs Market: Ambulatory Surgical Centers (2017-2022) & (K Units)

Figure 22. Global Immuno-oncology Drugs Sales Market Share by Application (2017-2022)

Figure 23. Global Immuno-oncology Drugs Revenue Market Share by Application in 2021

Figure 24. Immuno-oncology Drugs Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Immuno-oncology Drugs Revenue Market Share by Company in 2021

Figure 26. Global Immuno-oncology Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Immuno-oncology Drugs Revenue Market Share by Geographic Region in 2021

Figure 28. Global Immuno-oncology Drugs Sales Market Share by Region (2017-2022)

Figure 29. Global Immuno-oncology Drugs Revenue Market Share by Country/Region in 2021

Figure 30. Americas Immuno-oncology Drugs Sales 2017-2022 (K Units)

Figure 31. Americas Immuno-oncology Drugs Revenue 2017-2022 ($ Millions)

Figure 32. APAC Immuno-oncology Drugs Sales 2017-2022 (K Units)

Figure 33. APAC Immuno-oncology Drugs Revenue 2017-2022 ($ Millions)

Figure 34. Europe Immuno-oncology Drugs Sales 2017-2022 (K Units)

Figure 35. Europe Immuno-oncology Drugs Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Immuno-oncology Drugs Sales 2017-2022 (K Units)

Figure 37. Middle East & Africa Immuno-oncology Drugs Revenue 2017-2022 ($ Millions)

Figure 38. Americas Immuno-oncology Drugs Sales Market Share by Country in 2021

Figure 39. Americas Immuno-oncology Drugs Revenue Market Share by Country in 2021

Figure 40. United States Immuno-oncology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Immuno-oncology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Immuno-oncology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Immuno-oncology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Immuno-oncology Drugs Sales Market Share by Region in 2021

Figure 45. APAC Immuno-oncology Drugs Revenue Market Share by Regions in 2021

Figure 46. China Immuno-oncology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Immuno-oncology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Immuno-oncology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Immuno-oncology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Immuno-oncology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Immuno-oncology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Immuno-oncology Drugs Sales Market Share by Country in 2021

Figure 53. Europe Immuno-oncology Drugs Revenue Market Share by Country in 2021

Figure 54. Germany Immuno-oncology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Immuno-oncology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Immuno-oncology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Immuno-oncology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Immuno-oncology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Immuno-oncology Drugs Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Immuno-oncology Drugs Revenue Market Share by Country in 2021

Figure 61. Egypt Immuno-oncology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Immuno-oncology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Immuno-oncology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Immuno-oncology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Immuno-oncology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Immuno-oncology Drugs in 2021

Figure 67. Manufacturing Process Analysis of Immuno-oncology Drugs

Figure 68. Industry Chain Structure of Immuno-oncology Drugs

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles